If you’ve attempted to purchase an at-home COVID-19 test recently, you may have walked away from the store empty-handed. There’s been a nationwide shortage of at-home tests that hit at nearly the same time as the Omicron variant began to peak in almost every state.
The U.S. Supreme Court may have rejected a federal rule mandating COVID-19 vaccinations or testing, but businesses threatened by omicron’s spread might be forced to implement one anyway to protect the workers they have and keep factories open.
As the omicron variant sends U.S. Covid case numbers soaring to new records and drugstores and walk-in clinics clamor for test kits, suppliers have been struggling with their own mounting problems.
President Biden signed the $550 billion measure at a White House ceremony on Monday, after appointing a group of officials to guide the law’s enactment.
Management Sciences for Health, with funding from USAID and in cooperation with multiple private and public entities in Ukraine, launches a successful pilot to improve that country’s healthcare delivery supply chain.
More than 10 months after U.S. regulators first authorized its potent shot, Moderna is finding that inventing a COVID-19 vaccine was actually a relatively straightforward task compared with what would come next: ramping up vial-filling operations on multiple continents and distributing the vaccine to countries around the world in the middle of a devastating pandemic.
The latest supply-chain news, analysis, trends and tools for executives in the healthcare industry. Learn how healthcare companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.